The size of the Global Adhesion Barrier Market is forecasted to grow USD 1550 million by 2025 and was valued at USD 1034.9 million in 2020. This market is estimated to be growing at a CAGR of 8.48% during the forecast period.
An adhesion barrier is a medical implant that is used to decrease unusual internal scarring followed by surgery by detaching the internal tissues and organs during the time of healing. These barriers are used for surgical procedures in the department of gynecology, orthopedic, cardiovascular, reconstructive, and urological surgeries.
Drivers
The factors causing the adhesion barrier market growth is the growing elder people population which is incorporated with a number of surgical procedures performed among these elder people is one propelling the adhesion barrier market growth over the period. The growing occurrence rate of invasive surgeries with a high risk of postoperative difficulties is stirring up the market growth during the analysis period. The appearance of market key players focusing on the research and development of the adhesion barrier to come with the launch of new products and devices releasing into the market is one factor boosting the market growth over the period. Favorable reimbursement policies and having sound knowledge of the adhesion barrier market is fueling the growth during the period.
According to WHO, nearly an 8.2million people die each year suffering from cancer where a growing number of disease positively influences the market growth.
According to a survey which was conducted by the European Society for Gynecological Endoscopy, in the UK, nearly 85% of the respondents have approved that adhesions develop after any type of gynecology surgery and more than 50% of respondents have considered that adhesions are the most common problem of abdominal surgery.
As per the reports of the British Heart Association, there were 7.4million people who are living with circulatory and heart diseases as the heart and circulatory related diseases account for about 27% of deaths in the UK in 2019.
RESTRAINS
The cost associated with the treatment of surgeries is likely to hamper the market over the review period. Lack of awareness among the patients particularly people living in rural areas is one factor hindering the market growth. Strict rules and regulations associated with the product and device and therapeutic approvals restricting the market. Post-operative side effects where the patients who suffer the pain post-surgery may obstruct the market growth. Unfavorable government policies for the need of patients are limiting the growth. Moreover, limited applications of few product types may also obstruct the market. Difficult regulatory labyrinth which is the application of adhesion barriers that is limited to only a few surgical procedures may obstruct the market growth over the analysis period. The unwillingness of the adhesion barrier among the surgeons may hinder the market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Product, Product Form, Surgical Applications and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global adhesion barrier market has been segmented and sub-segmented based on the product, product form, surgical applications and region.
Adhesion Barrier Market – By Product:
Adhesion Barrier Market – By Product Form:
Adhesion Barrier Market – By Surgical Application:
Adhesion Barrier Market – By Region:
Regionally, North America is leading the global adhesion barrier market due to the presence of market leaders as well as well-developed healthcare infrastructure. However, Asia-Pacific is expected to grow the fastest due to increasing awareness regarding adhesion barriers, developing healthcare infrastructure and rising disposable income levels. Synthetic adhesion barriers hold a significant share in terms of products due to the widespread use of products such as hyaluronic acid and regenerated cellulose in surgeries. Film type adhesion barriers held a considerable share in terms of product form due to prevalent use in laparoscopic surgeries.
TOP COMPANIES IN THE MARKET
Some of the key players dominating the global adhesion barrier market profiled in this report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc. and MAST Biosurgery AG.
RECENT MARKET DEVELOPMENTS
On February 20, 2020, Baxter International has recently acquired Seprafilm Adhesion Barrier and associated effects and factors from Sanofi. Baxter’s advanced surgery provides clinically various surgical care products which are used in treating hemostasis, tissue sealing and tissue repair and many more.
On October 03, 2018, FzioMed introduced a new product Anti-Adhesion which is called Oxiplex/IU, which is an adhesion barrier gel for intrauterine surgery. The gel is used to uterine integrity and to make better surgical results by lessening the post-surgical adhesions.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods ]
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Synthetic Adhesion Barriers
5.1.2.1 Regenerated Cellulose
5.1.2.2 Hyaluronic Acid
5.1.2.3 Polythene Glycol
5.1.3 Natural Adhesion Barriers
5.1.3.1 Fibrin
5.1.3.2 Collagen & Protein
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Product Form
5.2.1 Introduction
5.2.2 Film Adhesion Barriers
5.2.3 Gel Adhesion Barriers
5.2.4 Liquid Adhesion Barriers
5.2.5 Y-o-Y Growth Analysis, By Product Form
5.2.6 Market Attractiveness Analysis, By Product Form
5.2.7 Market Share Analysis, By Product Form
5.3 Surgical Applications
5.3.1 Introduction
5.3.2 Gynaecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Neurological Surgeries
5.3.5 Orthopaedic Surgeries
5.3.6 General/Abdominal Surgeries
5.3.7 Urological Surgeries
5.3.8 Reconstructive Surgeries
5.3.9 Other Surgeries
5.3.10 Y-o-Y Growth Analysis, By Surgical Applications
5.3.11 Market Attractiveness Analysis, By Surgical Applications
5.3.12 Market Share Analysis, By Surgical Applications
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Product Form
6.1.3.4 By Surgical Applications
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Product Form
6.1.4.4 By Surgical Applications
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Product Form
6.1.5.4 By Surgical Applications
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc.
8.3 C. R. Bard, Inc.
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 Integra Lifesciences Corporation
8.8 Anika Therapeutics Inc.
8.9 FzioMed, Inc.
8.10 MAST Biosurgery AG
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
